The 36th ESCRS Congress will be organized by the European Cataract and Refractive Surgery Association in Wien/Austria on 22-26 September 2018. The Congress will enjoy the participation of international companies specialized in eye health who will present the latest innovations in the science of ophthalmology. While more than 10.000 visitors from all around the world are expected to attend the congress, VSY Biotechnology based in Holland will introduce its innovative trifocal intraocular lens Trinova. During the congress, the firm will attempt to meet with specialists in ophthalmology, introduce its innovative products to them, and organize other activities.
A NEW APPROACH TO TRIFOCAL INTRAOCULAR LENS TECHNOLOGY
VSY Biotechnology will carry out a Satellite Symposium during the Congress in order to introduce the world’s first and only sinusoidal formed trifocal intraocular lens AcrivaUD Trinova. In the symposium, which is to be organized on the 24th of September under the title “A New Approach to Trifocal Intraocular Lens Technology”, Dr. Roberto Belluci from Italy and Dr. Marko Hawlina from Slovenia will participate as moderators. The speakers in the symposium will be Dr. Ruth Rapid from Holland, Dr. Minoru Tomita from Japan, Dr. Ewa Mrukwa-Kominek from Poland and Dr. Johan Blanckaert from Belgium.
DOCTORS WILL DESCRIBE ACRIVA TRINOVA
Ophthalmologists from around the world who use VSY Biotechnology products will share their experiences and clinical results at the VSY Biotechnology stand during the Congress. Doctors that will forward information on the products will be Dr. Giacomo Savini and Dr. Andre Bedei from Italy, Dr. Pavel Stodulka from the Czech Republic, Dr. Pichit Naripthaphan from Thailand, Dr. Ante Barisic from Croatia, Dr. Petra Schollmayer from Slovenia, Dr. Jerome Bovet from Switzerland, and Dr. Pavol Vessely from Slovakia.
TRINOVA WILL BE RE-VISITED IN A SPECIAL SESSION
As part of the Congress program, Dr. John Blanckaert, who will participate in ESCRS from Belgium, will present a special statement about the new trifocal intraocular lens Trinova technology. In this special session to be held on 23rd of September as part of ESCRS program, Blanckaert will introduce unique features of Acriva Trinova and talk about his experiences.
PATENT APPLICATIONS ARE COMPLETED THROUGHOUT THE WORLD
Trinova lenses produced with Sinusoidal Vision Technology (SVT) by VSY Biotechnology are highly innovative and will enable cataract patients to see near, intermediate and far without any glasses. These lenses are applied to the eye by the ophthalmologists who remove the natural lens in the eye and replace it with the artificial lens. As a product to be closely examined by the doctors during the Congress, all patent applications throughout the world have been completed for Acriva Trinova.
VSY Biotechnology will meet with its visitors at the stand B510 during the activity to be organized in Reed Messe Congress center located in Wien/Austria.